Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
42 U.S.C. 1395w-3b Competitive acquisition of outpatient drugs and biologicals
42 U.S.C. 1395w-3b Competitive acquisition of outpatient drugs and biologicals, “Competitive acquisition of outpatient drugs and biologicals”, is a U.S. Code section of Part B—Supplementary Medical Insurance Benefits for Aged and Disabled; in force.
https://ontology.bommaritollc.com/id/01a0f07c-e102-70ca-a72a-207419ca07f9
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 42 U.S.C. 1395w-3b |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Competitive acquisition of outpatient drugs and biologicalsen |
| schema:url | |
| skos:prefLabel | 42 U.S.C. 1395w-3b Competitive acquisition of outpatient drugs and biologicalsen |
Related
Cited by (7)eli:cites
- 42 U.S.C. 1395l Payment of benefits
- 42 U.S.C. 1395u Provisions relating to the administration of part B
- 42 U.S.C. 1395w-3a Use of average sales price payment methodology
- 42 U.S.C. 1395w-4 Payment for physicians' services
- 42 U.S.C. 1395x Definitions
- 42 U.S.C. 1395y Exclusions from coverage and medicare as secondary payer
- 42 U.S.C. 1396r-8 Payment for covered outpatient drugs